Gilead Sciences
In David Rolfe's portfolio · Wedgewood Partners
Ticker GILD
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Wedgewood Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2014 | Sell | 0 | |
| Q1 2014 | Add 6% | 1,907,287 | 2.5% |
| Q4 2013 | Reduce 28% | 1,800,984 | 2.8% |
| Q3 2013 | Add 2% | 2,513,914 | 3.8% |
| Q2 2013 | First 13F | 2,459,512 | 3.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.